Sorafenib Terminated Phase 1 Trials for Leukemia Acute Myeloid Leukemia (AML) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02412475Epigenetic Reprogramming in Relapse AML